Parallax Volatility Advisers
XENT

Parallax Volatility Advisers’s Intersect ENT, Inc XENT Stock Holding History

Parallax Volatility Advisers’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-45,000
Closed -$1.27M – 4362
2018
Q4 		$1.27M Sell
45,000
-50,000
-53% -$1.46M ﹤0.01% 1225
2018
Q3 		$2.73M Buy
+95,000
New +$2.85M ﹤0.01% 931

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parallax Volatility Advisers's XENT Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Intersect ENT, Inc (XENT) in Q3 2019, closing a stake of 10 shares.

Parallax Volatility Advisers first reported a position in XENT in Q4 2017 and held it in 6 quarters. The position peaked at $1.23M in Q4 2018. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining Intersect ENT, Inc position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 10 Intersect ENT, Inc shares in Q3 2019.
  • Parallax Volatility Advisers first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's Intersect ENT, Inc position peaked at $1.23M in Q4 2018.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.